Published in Am J Trop Med Hyg on June 01, 2008
Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis. Parasit Vectors (2011) 1.02
Immune events associated with high level protection against Schistosoma japonicum infection in pigs immunized with UV-attenuated cercariae. PLoS One (2010) 0.96
Structure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control. Br J Pharmacol (2014) 0.86
Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bull World Health Organ (1968) 2.58
Schistosoma and related genera: acquired resistance in mice. Exp Parasitol (1983) 1.33
Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Trop (2005) 1.27
The potential of artemether for the control of schistosomiasis. Int J Parasitol (2001) 1.24
The prophylactic effects of artemether against Schistosoma japonicum infections. Parasitol Today (2000) 1.22
A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis. Int J Parasitol (2006) 1.17
In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob Agents Chemother (1989) 1.16
A double-blind field trial on the effects of artemether on Schistosoma japonicum infection in a highly endemic focus in southern China. Acta Trop (2005) 0.99
Experimental studies on early treatment of schistosomal infection with artemether. Southeast Asian J Trop Med Public Health (1995) 0.95
The relationship between pathology and resistance to reinfection with Schistosoma mansoni in mice: a causal mechanism of resistance in chronic infections. Parasitology (1987) 0.93
Differences in hepatic fibrosis and granuloma size in several strains of mice infected with Schistosoma japonicum. Am J Trop Med Hyg (1984) 0.91
Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits. Parasitol Int (2000) 0.89
Triggering of high-level resistance against Schistosoma mansoni reinfection by artemether in the mouse model. Am J Trop Med Hyg (2004) 0.84
Differences in adult Schistosoma mansoni worm burden requirements for the establishment of resistance to reinfection in inbred mice. II. C57BL/KsJ, SWR/J, SJL/J, BALB/cAnN, DBA/2N, A/J, B10.A(3R), and B10.A(5R) mice. Am J Trop Med Hyg (1983) 0.84
Differences in adult Schistosoma mansoni worm burden requirements for the establishment of resistance to reinfection in inbred mice. I. CBA/J and C57BL/6 mice. Am J Trop Med Hyg (1980) 0.84
Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. V. Reduction in the degree of resistance to reinfection after chemotherapeutic elimination of recently patent primary infections. J Helminthol (1980) 0.81
Tegumental alterations in juvenile Schistosoma haematobium harboured in hamsters following artemether treatment. Parasitol Int (2001) 0.81
Production of interleukin-10 by peripheral blood mononuclear cells from residents of a marshland area in China endemic for Schistosoma japonicum. Parasitol Int (1999) 0.80
Studies on chemotherapy of parasitic helminths: efficacy of artemether on Japanese strain of Schistosoma japonicum in mice. Southeast Asian J Trop Med Public Health (1993) 0.80
Factors affecting the acquisition of resistance to Schistosoma japonicum in the mouse. II. Evidence that resistance to reinfection is not mediated by specific effector mechanisms. Parasitology (1984) 0.79
Factors affecting the acquisition of resistance to Schistosoma japonicum in the mouse. I. The correlation between egg deposition and worm elimination. Parasitology (1984) 0.79
Schistosomiasis. N Engl J Med (2002) 7.48
Prevention and control of cystic echinococcosis. Lancet Infect Dis (2007) 3.64
Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect Dis (2010) 3.63
Enteropathogens and chronic illness in returning travelers. N Engl J Med (2013) 2.89
Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. Clin Infect Dis (2008) 2.80
Concepts in immunology and diagnosis of hydatid disease. Clin Microbiol Rev (2003) 2.77
IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections. Hepatology (2015) 2.76
Katayama syndrome. Lancet Infect Dis (2007) 2.71
Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med (2006) 2.59
New perspectives on host-parasite interplay by comparative transcriptomic and proteomic analyses of Schistosoma japonicum. PLoS Pathog (2006) 2.12
Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. Nat Genet (2003) 2.01
Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam. Clin Microbiol Rev (2010) 1.82
Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis (2010) 1.79
Towards a taxonomic revision of the genus Echinococcus. Trends Parasitol (2002) 1.68
A drug-based intervention study on the importance of buffaloes for human Schistosoma japonicum infection around Poyang Lake, People's Republic of China. Am J Trop Med Hyg (2006) 1.67
Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol (2010) 1.65
DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine (2008) 1.60
Diagnosis and management of schistosomiasis. BMJ (2011) 1.60
Vaccination of dogs against Echinococcus granulosus: a means to control hydatid disease? Trends Parasitol (2008) 1.58
Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China. Acta Trop (2002) 1.56
Developmental gene expression profiles of the human pathogen Schistosoma japonicum. BMC Genomics (2009) 1.56
Trick or treat: the role of vaccines in integrated schistosomiasis control. PLoS Negl Trop Dis (2008) 1.54
Mitochondrial genomes of parasitic flatworms. Trends Parasitol (2002) 1.45
Zoonoses and marginalised infectious diseases of poverty: where do we stand? Parasit Vectors (2011) 1.44
The cytoskeleton and motor proteins of human schistosomes and their roles in surface maintenance and host-parasite interactions. Bioessays (2004) 1.42
Recent advances in the immunology and diagnosis of echinococcosis. FEMS Immunol Med Microbiol (2006) 1.42
Health-education package to prevent worm infections in Chinese schoolchildren. N Engl J Med (2013) 1.39
Clonorchis sinensis and Opisthorchis viverrini: development of a mitochondrial-based multiplex PCR for their identification and discrimination. Exp Parasitol (2005) 1.38
The secreted and surface proteomes of the adult stage of the carcinogenic human liver fluke Opisthorchis viverrini. Proteomics (2010) 1.35
Serological prevalence of echinococcosis and risk factors for infection among children in rural communities of southern Ningxia, China. Trop Med Int Health (2008) 1.35
A cluster-randomized bovine intervention trial against Schistosoma japonicum in the People's Republic of China: design and baseline results. Am J Trop Med Hyg (2007) 1.34
Mechanisms of immunity in hydatid disease: implications for vaccine development. J Immunol (2008) 1.33
A cluster-randomised intervention trial against Schistosoma japonicum in the Peoples' Republic of China: bovine and human transmission. PLoS One (2009) 1.32
Transmission dynamics of Schistosoma japonicum in the lakes and marshlands of China. PLoS One (2008) 1.32
A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury. J Immunol (2005) 1.30
The genome of the hydatid tapeworm Echinococcus granulosus. Nat Genet (2013) 1.29
Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J Immunol (2011) 1.28
Suppression of mRNAs encoding tegument tetraspanins from Schistosoma mansoni results in impaired tegument turnover. PLoS Pathog (2010) 1.26
Community surveys and risk factor analysis of human alveolar and cystic echinococcosis in Ningxia Hui Autonomous Region, China. Bull World Health Organ (2006) 1.24
Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age. J Infect Dis (2012) 1.23
Diagnosis of cystic echinococcosis, central Peruvian Highlands. Emerg Infect Dis (2008) 1.23
Large water management projects and schistosomiasis control, Dongting Lake region, China. Emerg Infect Dis (2007) 1.23
Immunology and immunodiagnosis of cystic echinococcosis: an update. Clin Dev Immunol (2011) 1.21
Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea. Infect Immun (2009) 1.20
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial. PLoS Med (2012) 1.20
Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3. J Invest Dermatol (2003) 1.19
Prevalence, intensity and associated morbidity of Schistosoma japonicum infection in the Dongting Lake region, China. Bull World Health Organ (2007) 1.19
A novel recombinant antigen for immunodiagnosis of human cystic echinococcosis. J Infect Dis (2003) 1.18
Placental malaria-associated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation. J Infect Dis (2011) 1.18
Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis. PLoS Negl Trop Dis (2010) 1.18
Exposed proteins of the Schistosoma japonicum tegument. Int J Parasitol (2009) 1.18
A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis. Int J Parasitol (2006) 1.17
Transcriptomics tool for the human Schistosoma blood flukes using microarray gene expression profiling. Exp Parasitol (2006) 1.16
Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women. Infect Immun (2010) 1.15
Tracking the fate of iron in early development of human blood flukes. Int J Biochem Cell Biol (2007) 1.14
Human fascioliasis and the presence of hybrid/introgressed forms of Fasciola hepatica and Fasciola gigantica in Vietnam. Int J Parasitol (2007) 1.14
Plasmodium strain determines dendritic cell function essential for survival from malaria. PLoS Pathog (2007) 1.12
A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China. Bull World Health Organ (2008) 1.11
Multiple near-identical genotypes of Schistosoma japonicum can occur in snails and have implications for population-genetic analyses. Int J Parasitol (2008) 1.11
Tissue specific profiling of females of Schistosoma japonicum by integrated laser microdissection microscopy and microarray analysis. PLoS Negl Trop Dis (2009) 1.10
Transcriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytes. PLoS Negl Trop Dis (2010) 1.10
Bayesian risk maps for Schistosoma mansoni and hookworm mono-infections in a setting where both parasites co-exist. Geospat Health (2007) 1.10
Cloning and characterisation of Schistosoma japonicum insulin receptors. PLoS One (2010) 1.10
Oligonucleotide microarray analysis of strain- and gender-associated gene expression in the human blood fluke, Schistosoma japonicum. Mol Cell Probes (2006) 1.09
Schistosome transcriptomes: new insights into the parasite and schistosomiasis. Trends Mol Med (2004) 1.09
Placental infection with Plasmodium vivax: a histopathological and molecular study. J Infect Dis (2012) 1.09
Heme and blood-feeding parasites: friends or foes? Parasit Vectors (2010) 1.07
The ultrastructural architecture of the adult Schistosoma japonicum tegument. Int J Parasitol (2003) 1.05
Update on paramyosin in parasitic worms. Parasitol Int (2005) 1.04
Differential diagnosis of Taenia saginata and Taenia saginata asiatica taeniasis through PCR. Diagn Microbiol Infect Dis (2004) 1.03
Schistosomiasis vaccine discovery using immunomics. Parasit Vectors (2010) 1.03
Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis. Immunol Rev (2004) 1.03
A 5-year longitudinal study of schistosomiasis transmission in Shian village, the Anning River Valley, Sichuan Province, the Peoples' Republic of China. Parasit Vectors (2011) 1.03